Abstract:10-Hydroxycamptothecin (HCPT) is insoluble in both water and physiological acceptable organic solvents and tends to change into its carboxylate form, which shows minimal anticancer activity and several unpredictable side effects. The goal of this study is to exploit an appropriate delivery system for HCPT to improve the stability of its lactone form. Bovine serum albumin (BSA) nanoparticles entrapping HCPT were prepared by reformative emulsion-heat stabilization technique. During this process, HCPT transformed from lactone to carboxylate and finally back to lactone form successfully. A simple reversed-phased HPLC method was developed to analyze both lactone and carboxylate forms of HCPT synchronously. Mean particle size and the ratio of lactone and carboxylate forms of HCPT were evaluated to investigate the effects of the formulations and preparation conditions. It was indicated the percentage of lactone form of HCPT in resultant BSA nanoparticles could be improved over 95% through adjusting the concentration of NaOH solution and the stirring time after high-speed emulsification. This drug delivery system was also characterized by dynamic light scattering (DLS) and light microscopy. The investigations on drug loading, in vitro release and body distribution in rats after intravenous (i.v.) administration were also carried out. It was found that the obtained nanoparticles showed spherical shape with the mean particle size of around 600 nm, and drug loading content, encapsulation efficiency and yield achieved 2.21%, 57.5% and 90.5% with the optimal preparation conditions, respectively. The in vitro release behavior exhibited a sustaining release manner and was affected by the trypsin in medium. HCPT could release more than 90% within 20 h in the medium of pH 7.4 PBS containing 750 U/ml trypsin, but only 25% within 40 h in the pure pH 7.4 PBS. The results of body distribution study in rats showed the liver targeting potential of HCPT-BSA nanoparticles that 59.6%, 52.9% and 55.3% of the examined amount of lactone HCPT accumulated in livers at 1, 4 and 24h after injection, respectively. These results suggest that the HCPT-BSA nanoparticles seem to be a stable delivery system for poorly soluble HCPT or its derivatives.

Preparation of BSA-coated cationic nanostructure lipid carriers and pharmacokinetics and biodistribution after intravenous injection

Interactions of Self-Assembled Bletilla S triata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles.

Preparation of stable and monodisperse paclitaxel-loaded bovine serum albumin nanoparticles via intermolecular disulfide crosslinking

Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer

Preparation and Characterization of 10-Hydroxycamptothecin Loaded Nanostructured Lipid Carriers

Preparation and in Vitro Release of Poly(Butyl Cyanoacrylate) Nanocapsules with an Aqueous Core Containing Bovine Serum Albumin

Nanocomplex Based on Biocompatible Phospholipids and Albumin for Long-Circulation Applications.

Preparation, Characterization and Pharmacokinetics of Amoitone B-loaded Long Circulating Nanostructured Lipid Carriers.

Preparation and Characterization of Sodium Ferulate Entrapped Bovine Serum Albumin Nanoparticles for Liver Targeting

Preparation and Characterization of a Nanostructured Lipid Carrier for a Poorly Soluble Drug

Pharmacokinetics and Biodistribution of Surface Modification Polymeric Nanoparticles

Drug-binding albumins forming stabilized nanoparticles for efficient anticancer therapy.

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.

Preparation and Characterization of Paclitaxel-Loaded DSPE-PEG-liquid Crystalline Nanoparticles (lcnps) for Improved Bioavailability

Brain Delivery and Systemic Effect of Cationic Albumin Conjugated PLGA Nanoparticles.

MULTILAYERS AND POLY（ALLYLAMINE HYDROCHLORIDE）-GRAFT- POLY（ETHYLENE GLYCOL） MODIFIED BOVINE SERUM ALBUMIN NANOPARTICLES： IMPROVED STABILITY AND Ph-Responsive DRUG DELIVERY

Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution

Preparation,Characterization and in vitro Release Behaviour of BSA Loaded Microcapsules

[Optimization of formulation of paclitaxel nanosuspension encapsulated by erythrocyte membrane based on Box-Behnken method]

Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer